A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138] |
Brentjens, Renier |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase I Study of Genetically Modified T Cells Targeting CD19 in Pediatric and Young Adult Patients with Relapsed B-Cell Acute Lymphoblastic Leukemia
[Protocol 13-052] |
Curran, Kevin |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Study of GC33 plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
[Protocol 10-021] |
Abou-Alfa, Ghassan |
|
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181] |
Tallman, Martin |
- Hematology
- Hematologic Malignancies
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
|
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155] |
Traina, Tiffany |
|
A Phase I Study of DSTP3086S in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 11-016] |
Danila, Daniel |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083] |
Carvajal, Richard |
|
A Phase I Study of Dabrafenib and Ipilimumab with and without Trametinib for Advanced Melanoma
[Protocol 12-285] |
Wolchok, Jedd |
|
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
[Protocol 13-045] |
Younes, Anas |
|
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011] |
Souweidane, Mark |
|
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048] |
Park, Jae |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase I Study of Carboxyamidotriazole Orotate Plus Temozolomide in Patients with Glioblastoma Multiforme and Other Recurrent Malignant Gliomas
[Protocol 12-007] |
Omuro, Antonio |
|
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106] |
Bell-McGuinn, Katherine |
|
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
[Protocol 13-021] |
Trippett, Tanya |
- Pediatric Brain Tumors
- Primary Bone
- Sarcomas
- Solid Tumors
|
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027] |
Dickler, Maura |
|
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer |
- Lung Cancer, Non-Small Cell
- Melanoma
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Solid Tumors
|
A Phase I Study of BMS-986015 plus BMS-936558 in Patients with Advanced Solid Tumors
[Protocol 12-224] |
Segal, Neil |
- Colorectal Cancer
- Kidney Cancer
- Lung Cancer, Non-Small Cell
- Melanoma
- Ovarian Cancer
|
A Phase I Study of BMS-936558 with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of BMS-936558 in Patients with Relapsed or Refractory Hematologic Cancers
[Protocol 12-142] |
Lesokhin, Alexander |
- Hematology
- Leukemia
- Chronic Myelocytic Leukemia
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of BMS-936558 in Combination with Sunitinib or Pazopanib in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147] |
Voss, Martin |
|
